Evidence map›Paper›PMID 30636257›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2019

Antidepressive Effects of Taraxacum Officinale in a Mouse Model of Depression Are Due to Inhibition of Corticosterone Levels and Modulation of Mitogen-Activated Protein Kinase Phosphatase-1 (Mkp-1) and Brain-Derived Neurotrophic Factor (Bdnf) Expression.

Cunyou Gao, Suli Kong, Benyu Guo, Xuejun Liang, Huifeng Duan, Donghe Li

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Cunyou GaoJiading District Mental Health Center, Shanghai, China (mainland).
Suli KongJiading District Mental Health Center, Shanghai, China (mainland).
Benyu GuoJiading District Mental Health Center, Shanghai, China (mainland).
Xuejun LiangMental Diseases Prevention and Treatment Institute of Chinese People's Liberation Army (PLA), PLA 91st Central Hospital, Jiaozuo, Henan, China (mainland).
Huifeng DuanMental Diseases Prevention and Treatment Institute of Chinese People's Liberation Army (PLA), PLA 91st Central Hospital, Jiaozuo, Henan, China (mainland).
Donghe LiMental Diseases Prevention and Treatment Institute of Chinese People's Liberation Army (PLA), PLA 91st Central Hospital, Jiaozuo, Henan, China (mainland).
Chinese People's Liberation Army · CNJiading District Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Depression is a common disorder linked with high levels of chronicity, psycho-social and physical problems, and suicide. Here, we assessed the antidepressant effects of the hydromethanolic extract of Taraxacum officinale and investigated the underlying mechanism. MATERIAL AND METHODS Antidepressant effects were examined by use of the tail suspension test (TST). Concentrations of corticosterone, dopamine, noradrenaline, and adrenaline were examined by biochemical assays. The mRNA expression was assessed by quantitative RT-PCR. Phytochemical analysis was performed by LC/MS. RESULTS The results showed that the extract at the dosage of 50 and 100 mg/kg significantly (p<0.01) alleviated the TST-induced immobility in the mice, and the effects were comparable to the antidepressant drug Bupropion, which was used as the positive control. Investigation of the underlying mechanism revealed that the T. officinale extract exerts it effects by significantly (p<0.05) decreasing the levels of corticosterone and increasing the concentrations of dopamine, noradrenaline, and adrenaline. Further, the extract also increased the expression of brain-derived neurotrophic factor (Bdnf), which was associated with significant (p<0.05) decrease in the expression of mitogen-activated protein kinase phosphatase-1 (Mkp-1), indicative of the antidepressant potential of T. officinale. Finally, the active constituents of the extract, which include isoetin, hesperidin, naringenin, Kaempferol, sinapinic, and gallic acid, were also identified, which could potentially be responsible for its antidepressant effects. CONCLUSIONS In conclusion, T. officinale exerts significant antidepressant effects in a mouse model of depression by inhibition of corticosterone levels and modulation of Mkp-1 and Bdnf expression.

Indexed as

AnimalsAntidepressive AgentsBehavior, AnimalBrain-Derived Neurotrophic FactorCorticosteroneDepressionDepressive DisorderDisease Models, AnimalDopamineDual Specificity Phosphatase 1EpinephrineMaleMiceMice, Inbred ICRNorepinephrinePhytotherapyAntidepressive AgentsBrain-Derived Neurotrophic FactorCorticosteroneDopamineDual Specificity Phosphatase 1Dusp1 protein, mouseEpinephrineNorepinephrinePlant Extracts

Identifiers

PMID30636257
PMCPMC6340315
OpenAlexW2909185714

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.